Your browser doesn't support javascript.
loading
Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial.
Mitsuya, Koichi; Akiyama, Yasuto; Iizuka, Akira; Miyata, Haruo; Deguchi, Shoichi; Hayashi, Nakamasa; Maeda, Chie; Kondou, Ryota; Kanematsu, Akari; Watanabe, Kyoko; Ashizawa, Tadashi; Abe, Yoshiaki; Ito, Ichiro; Oishi, Takuma; Sugino, Takashi; Nakasu, Yoko; Yamaguchi, Ken.
Afiliación
  • Mitsuya K; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Akiyama Y; Division of Neurosurgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Iizuka A; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan y.akiyama@scchr.jp.
  • Miyata H; Division of Neurosurgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Deguchi S; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Hayashi N; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Maeda C; Division of Neurosurgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Kondou R; Division of Neurosurgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Kanematsu A; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Watanabe K; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Ashizawa T; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Abe Y; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Ito I; Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Oishi T; Division of Blood Transfusion,, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Sugino T; Division of Pathology, Nagano Red Cross Hospital, Nagano, Japan.
  • Nakasu Y; Division of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Yamaguchi K; Division of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Anticancer Res ; 40(11): 6473-6484, 2020 Nov.
Article en En | MEDLINE | ID: mdl-33109586
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Células Dendríticas / Vacunas contra el Cáncer / Glioma / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Células Dendríticas / Vacunas contra el Cáncer / Glioma / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Japón